NDAQ:GILD - Post Discussion
Post by
whytestocks on Jul 14, 2023 3:00pm
FDA Approves Veklury® (Remdesivir) for COVID-19 Treatme
NEWS: $GILD FDA Approves Veklury® (Remdesivir) for COVID-19 Treatment in Patients With Severe Renal Impairment, Including Those on Dialysis-- Veklury is Now the First Approved Antiviral Treatment for Patients Across all Stages of Renal Disease -- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) approved a supplemental new drug application (sNDA) for the use of Veklury ...
GILD - FDA Approves Veklury® (Remdesivir) for COVID-19 Treatment in Patients With Severe Renal Impairment, Including Those on Dialysis
Be the first to comment on this post